Market Overview:
The global bronchitis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of bronchitis, increasing awareness about available treatments, and growing demand for home-based care. Based on type, the global bronchitis treatment market is segmented into drugs and oxygen therapy. The drugs segment is further sub-segmented into antibiotics, anti-inflammatory agents, mucolytics, and others (corticosteroids and expectorants). The oxygen therapy segment is further sub-segmented into high flow oxygen therapy and low flow oxygen therapy. Based on application, the global bronchitis treatment market is divided into hospitals, clinics, and drug stores. Geographically speaking North America dominates the global Bronchitis Treatment Market followed by Europe due to increase in geriatric population which are highly susceptible to Bronchiectasis & Chronic Obstructive Pulmonary Disease (COPD) conditions across these regions respectively .
Product Definition:
Bronchitis is a respiratory infection that is typically caused by the common cold or flu. Bronchitis can cause chest congestion, coughing, and difficulty breathing. Treatment for bronchitis typically includes antibiotics to kill the bacteria that may be causing the infection, as well as over-the-counter medications to help relieve symptoms. Bronchitis treatment may also include chest physiotherapy to loosen mucus and promote healing, and inhalers or steroids to help reduce inflammation.
Drugs:
The global drugs, it's usage and growth factor in bronchitis treatment market is expected to grow at a significant rate during the forecast period. The major factor that propels the growth of this market is increasing prevalence of chronic diseases like asthma, Chronic Obstructive Pulmonary Disease (COPD), and bronchitis. According to the World Health Organization (WHO) estimates published in 2012, approximately 1 billion people were suffering from COPD worldwide which includes both developed and developing countries.
Oxygen therapy:
Oxygen therapy is a medical treatment in which oxygen-rich air is provided to the patient. Oxygen has been proved to be effective in treating bronchitis and other respiratory diseases. It helps restore the blood flow and increases oxygen content in tissues, thus reducing pain and fever. The medicine usually given along with oxygen contains antibiotics for preventing bacterial infection of lungs.
Application Insights:
Based on the application, the global bronchitis treatment market is segmented into hospitals, clinics and drug stores. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities along with a large number of Bronchitis patients. In addition, hospital based settings are more likely to administer O2 therapy as it is less expensive than outpatient treatments.
Bronchitis Treatment in clinics accounted for a significant share as compared to hospitals due to convenience and accessibility offered by clinic based settings at comparatively lower costs when compared with hospital visits. Bronchitis patients suffering from acute respiratory infections may require admission for proper management which may further increase treatment costs in case of an emergency admission or transferral to an intensive care unit (ICU).
Regional Analysis:
North America dominated the global bronchitis treatment market in 2017. The rising prevalence of respiratory infections and increasing number of surgeries for chronic obstructive pulmonary disease are some factors responsible for its large share. According to the CDC, around 12 million people were diagnosed with COPD in 2015 and it is expected to increase to 21 million by 2035. In addition, growing awareness about various treatments available along with high healthcare expenditure levels in this region are some factors contributing towards its large share.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing cases of infectious diseases such as bronchitis and asthma among children & adolescents as well as adults which is leading toward an increased demand for effective treatment methods that help control these diseases efficiently.
Growth Factors:
- Increasing incidence of bronchitis
- Rising awareness about the benefits of bronchitis treatment
- Growing demand for home-based treatments for bronchitis
- Technological advancements in bronchitis treatment therapies
- Availability of government funding for research and development in bronchitis treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Bronchitis Treatment Market Research Report
By Type
Drugs, Oxygen therapy
By Application
Hospitals, Clinics, Drug stores
By Companies
Pfizer, GlaxoSmithKline Pharmaceuticals Limited, Sanofi Aventis, Boehringer Ingelheim, Dr. Reddy’s Laboratories Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Bronchitis Treatment Market Report Segments:
The global Bronchitis Treatment market is segmented on the basis of:
Types
Drugs, Oxygen therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Drug stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GlaxoSmithKline Pharmaceuticals Limited
- Sanofi Aventis
- Boehringer Ingelheim
- Dr. Reddy’s Laboratories Ltd
Highlights of The Bronchitis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drugs
- Oxygen therapy
- By Application:
- Hospitals
- Clinics
- Drug stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bronchitis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bronchitis is an infection of the airways that can be caused by a number of different things, including the common cold, the flu, or other respiratory infections. Bronchitis treatment typically involves taking antibiotics to clear up the infection and relieve symptoms. In some cases, bronchitis may require surgery to remove blockages in the airways.
Some of the major players in the bronchitis treatment market are Pfizer, GlaxoSmithKline Pharmaceuticals Limited, Sanofi Aventis, Boehringer Ingelheim, Dr. Reddy’s Laboratories Ltd.
The bronchitis treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bronchitis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bronchitis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bronchitis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bronchitis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bronchitis Treatment Market Size & Forecast, 2020-2028
4.5.1 Bronchitis Treatment Market Size and Y-o-Y Growth
4.5.2 Bronchitis Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Drugs
5.2.2 Oxygen therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Drug stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bronchitis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bronchitis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Drugs
9.6.2 Oxygen therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Drug stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Drugs
10.6.2 Oxygen therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Drug stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Drugs
11.6.2 Oxygen therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Drug stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Drugs
12.6.2 Oxygen therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Drug stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Drugs
13.6.2 Oxygen therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Drug stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bronchitis Treatment Market: Competitive Dashboard
14.2 Global Bronchitis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GlaxoSmithKline Pharmaceuticals Limited
14.3.3 Sanofi Aventis
14.3.4 Boehringer Ingelheim
14.3.5 Dr. Reddy’s Laboratories Ltd
